Matthew Might's primary research area is static analysis of higher-order programs. His broader interests include language design, compiler implementation, security, program optimization, parallelism and program verification.

He runs the U Combinator software systems research group. He is available as an expert witness on subjects within his expertise. With respect to his reports, he is willing to be deposed and to testify.

His son Bertrand was the first patient ever discovered with a rare disorder known as N-Glycanase deficiency. He wrote an essay about the process of scientific discovery, and the aftermath has been covered by an article in The New Yorker and in Der Spiegel.

More of his interests span to static analysis, compilers, functional programming, cybersecurity, information security, optimization, medical robotics, parallelism, high-performance computing, scripting languages, dynamic languages and genetics.

Programmers, Cybersecurity, Technology, Information Technology, Robotics, Healthcare, Computer Science, Genetics, Science, Research & Exploration, Research Scientist Innovation, Creativity,